市场调查报告书
商品编码
1349210
心臟封堵装置市场 - 依产品(心房中隔缺损 (ASD) 封堵装置、左心耳 (LAA) 封堵装置)、依材质(镍钛诺基装置、不锈钢装置)、交付方式、最终用途及预测, 2023 - 2032Heart Closure Devices Market - By Product (Atrial Septal Defect (ASD) Closure Devices, Left Atrial Appendage (LAA) Closure Devices), By Material (Nitinol-based Devices, Stainless Steel Devices), Mode of Delivery, End-use & Forecast, 2023 - 2032 |
2023年至2032年,全球心臟闭合装置市场的复合年增长率将达到12.2%。全球心血管疾病发生率的上升推动了对微创手术的需求。据世界卫生组织称,每年,心血管疾病 (CVD) 导致全球约 1,790 万人死亡,巩固了其作为主要死因的地位。
经皮封堵心房中隔缺损和卵圆孔未闭等手术推动了对心臟封堵装置的需求。此外,技术进步提高了这些设备的安全性和有效性,吸引了患者和医疗保健提供者,从而促进了市场成长。此外,人口老化的加剧以及人们对这些设备益处的认识不断增强,将增强心臟闭合设备的市场前景,直至 2032 年。
整个心臟闭合装置市场根据产品、材料、最终用途和地区进行分类。
就产品而言,2023年至2032年,房间隔缺损(ASD)细分市场将以12.6%的复合年增长率扩张。ASD是一种先天性心臟病,心房之间存在孔洞,导致血流异常。这些装置(例如房间隔封堵器)提供了一种微创解决方案来闭合缺损,从而降低併发症的风险并改善患者的生活品质。随着人们对自闭症谱系障碍 (ASD) 认识的不断提高和设备技术的进步,对治疗这种疾病的心臟闭合设备的需求正在稳步增长。
从材料来看,从2023 年到2032 年,另一个细分市场的复合年增长率将达到12.5%。对改善生物相容性和降低患者过敏或不良反应风险的需求正在推动该细分市场的增长。生物可吸收聚合物和钛合金等材料因其良好的特性而越来越受欢迎。这些材料不仅提高了患者的安全性,还为微创手术提供了创新的解决方案,将市场范围扩大到传统选择之外。
就最终用途而言,心导管实验室细分市场在 2023 年至 2032 年期间的复合年增长率将达到 12.3%。心导管实验室处于微创心臟手术的最前线。心臟闭合装置,如房间隔封堵器和血管塞,越来越多地在此类环境中使用,以治疗房间隔缺损和卵圆孔未闭等疾病。它们的有效性、安全性和缩短的恢復时间使它们成为这些专业设施中必不可少的工具。
从地区来看,2023年至2032年,亚太地区心臟闭合装置市场的复合年增长率将达到13.3%。由于各国心血管疾病盛行率不断上升,推动了对微创治疗方案的需求,该市场正在蓬勃发展。此外,随着人口老化的加剧,医疗保健基础设施的改善和医疗保健意识的提高也有助于市场的扩张。随着亚太地区继续优先考虑心血管健康,心臟闭合装置市场收入将在未来几年大幅成长。
Global Heart Closure Devices Market will witness a 12.2% CAGR between 2023 and 2032. The rising incidence of cardiovascular diseases worldwide has propelled the demand for minimally invasive procedures. According to WHO, each year, cardiovascular diseases (CVDs) are responsible for approximately 17.9 million fatalities worldwide, solidifying their position as the leading cause of death.
Procedures like percutaneous closure of atrial septal defects and patent foramen ovale propel the need for heart closure devices. Additionally, technological advancements have improved the safety and efficacy of these devices, attracting both patients and healthcare providers, thus contributing to market growth. Moreover, the increasing aging population and growing awareness of the benefits of these devices will strengthen the heart closure devices market outlook through 2032.
The overall Heart Closure Devices Market is classified based on product, material, end-use, and region.
With respect to product, the Atrial Septal Defect (ASD) segment will expand at a 12.6% CAGR from 2023 to 2032. ASD is a congenital heart condition in which a hole exists between the atria, leading to abnormal blood flow. These devices, such as septal occluders, offer a minimally invasive solution to close the defect, reducing the risk of complications and improving patients' quality of life. With growing awareness of ASD and advancements in device technology, the demand for heart closure devices in managing this condition is steadily increasing.
By material, the other segment will register a 12.5% CAGR from 2023 to 2032. The need for improved biocompatibility and reduced risk of allergies or adverse reactions in patients is driving segment growth. Materials like bioabsorbable polymers and titanium alloys are gaining popularity due to their favorable attributes. These materials not only enhance patient safety but also offer innovative solutions for minimally invasive procedures, expanding the market's scope beyond traditional choices.
Regarding the end-use, the cardiac catheterization laboratories segment will exhibit a 12.3% CAGR over 2023-2032. Cardiac catheterization labs are at the forefront of minimally invasive cardiac procedures. Heart closure devices, like septal occluders and vascular plugs, are increasingly utilized in such settings to treat conditions like atrial septal defects and patent foramen ovale. Their effectiveness, safety, and reduced recovery times make them essential tools in these specialized facilities.
Regionally, the Asia Pacific heart closure devices market will record a 13.3% CAGR from 2023 to 2032. The market is thriving due to the increasing prevalence of cardiovascular diseases in countries driving the need for minimally invasive treatment options. Additionally, improving healthcare infrastructure and rising healthcare awareness, in line with the growing aging population, are contributing to the market expansion. As the Asia-Pacific region continues to prioritize cardiovascular health, the heart closure devices market revenue is set for substantial growth in the coming years.